• Je něco špatně v tomto záznamu ?

On the solubility and lipophilicity of metallacarborane pharmacophores

J. Rak, B. Dejlová, H. Lampová, R. Kaplánek, P. Matějíček, P. Cígler, V. Král,

. 2013 ; 10 (5) : 1751-9.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14040871

Metallacarborane moieties have been identified as promising pharmacophores. The pharmaceutical use of such compounds is, however, complicated by their low solubility and tendency to self-assemble in aqueous solution. In this work, we estimated the solubilities of a vast series of metallacarboranes [cobalt bis(dicarbollide) derivatives] in pure water, saline, and saline with human serum albumin as a model of blood plasma. In addition, we determined the octanol-water partition coefficients (Pow) as a lipophilicity descriptor. Pow weakly correlates with the water solubility of metallacarboranes, whereas the ability of HSA to increase the solubility of metallacarboranes correlates well with their Pow values. Because metallacarboranes are known inhibitors of HIV protease, the possible correlation between Pow and the ability to inhibit HIV protease was investigated. Results from this study indicate that interaction of metallacarborane inhibitors with HIV protease is driven by specific binding rather than by promiscuous lipophilic interactions. The most promising candidates for further drug development were identified by ligand lipophilicity efficiency analysis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040871
003      
CZ-PrNML
005      
20140114102326.0
007      
ta
008      
140107s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/mp300565z $2 doi
035    __
$a (PubMed)23506420
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rak, Jakub
245    10
$a On the solubility and lipophilicity of metallacarborane pharmacophores / $c J. Rak, B. Dejlová, H. Lampová, R. Kaplánek, P. Matějíček, P. Cígler, V. Král,
520    9_
$a Metallacarborane moieties have been identified as promising pharmacophores. The pharmaceutical use of such compounds is, however, complicated by their low solubility and tendency to self-assemble in aqueous solution. In this work, we estimated the solubilities of a vast series of metallacarboranes [cobalt bis(dicarbollide) derivatives] in pure water, saline, and saline with human serum albumin as a model of blood plasma. In addition, we determined the octanol-water partition coefficients (Pow) as a lipophilicity descriptor. Pow weakly correlates with the water solubility of metallacarboranes, whereas the ability of HSA to increase the solubility of metallacarboranes correlates well with their Pow values. Because metallacarboranes are known inhibitors of HIV protease, the possible correlation between Pow and the ability to inhibit HIV protease was investigated. Results from this study indicate that interaction of metallacarborane inhibitors with HIV protease is driven by specific binding rather than by promiscuous lipophilic interactions. The most promising candidates for further drug development were identified by ligand lipophilicity efficiency analysis.
650    _2
$a sloučeniny boru $x chemie $x farmakologie $7 D001896
650    _2
$a kobalt $x chemie $x farmakologie $7 D003035
650    _2
$a objevování léků $7 D055808
650    _2
$a inhibitory HIV-proteasy $x chemie $x farmakologie $7 D017320
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    _2
$a lipidy $x chemie $7 D008055
650    _2
$a molekulární struktura $7 D015394
650    _2
$a organokovové sloučeniny $x chemie $x farmakologie $7 D009942
650    _2
$a sérový albumin $x chemie $7 D012709
650    _2
$a rozpustnost $7 D012995
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dejlová, Barbora $u -
700    1_
$a Lampová, Hana $u -
700    1_
$a Kaplánek, Robert $u -
700    1_
$a Matějíček, Pavel $u -
700    1_
$a Cígler, Petr $u -
700    1_
$a Král, Vladimír $u -
773    0_
$w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 10, č. 5 (2013), s. 1751-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23506420 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20140114103030 $b ABA008
999    __
$a ok $b bmc $g 1005267 $s 839383
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 10 $c 5 $d 1751-9 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
LZP    __
$a Pubmed-20140107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...